PCN13 REAL LIFE OUTCOMES IN 2ND LINE ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC)- A PILOT STUDY IN FRANCE AND GERMANY ANALYSING ERLOTINIB VERSUS CHEMOTHERAPY
May 1, 2011, 00:00
10.1016/j.jval.2011.02.871
https://www.valueinhealthjournal.com/article/S1098-3015(11)01010-2/fulltext
Title :
PCN13 REAL LIFE OUTCOMES IN 2ND LINE ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC)- A PILOT STUDY IN FRANCE AND GERMANY ANALYSING ERLOTINIB VERSUS CHEMOTHERAPY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01010-2&doi=10.1016/j.jval.2011.02.871
First page :
A157
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
340